Dr. Richard Thompson received a Bachelors degree in Biomedical Science from Kings’ College London, in 2000. During which, he spent a year in the Cancer Virology Team at St. Thomas’ Hospital, London investigating Human Papillomavirus 16 E5 variants. On completing his degree, He went to work in the Laboratory of Prof. Polly Roy at the London School of Hygiene and Tropical Medicine, using insect and mammalian systems to investigate the structure and function of Bluetongue Virus VP1 and NS3 proteins.
During this time, Dr. Thompson developed an interest in Computational Biology, leading to the successful completion of a Masters in Bioinformatics at Birkbeck College, London in 2005. This was followed by a Doctorate in Biostatistics and Virology, during which he participated in the EuResist project, examining data relating to over 16,000 HIV patients across Europe in relation to treatment response, adherence metrics and viral phylogeny.
Dr. Thompson then worked at the Wellcome Trust Sanger Institute, Cambridge as a Computational Biologist, playing a significant role in the Genomics of Drug Sensitivity in Cancer project (www.cancerRxgene.org
). In June 2012, Dr. Thompson joined Shafallah Medical Genetics Center as a Bioinformatics Analyst, continuing his work within the center through the merger with QBRI.
Dr. Thompson’s research interests lie in the development and application of machine learning algorithms to complex biomedical questions.
In addition, Dr. Thompson is committed to enabling the application of computational techniques to support the work carried out in the labs and to ensuring that his colleagues have the tools and experience necessary to take advantage of the computational aspects of their work.